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Because ultraviolet-A1 (UVA1; 340–400 nm) radiation
is used therapeutically, this in vitro study addressed the
question ‘‘how does it work?’’ To begin addressing
this question, UVA1 radiation was first established to
reduce the survival of transformed T and B lympho-
cytes in a linear dose-dependent manner using clono-
genic reproductive assays, and that cell death occurs
by apoptosis using transmission electron microscopy,
Annexin V, and flow cytometry. The primary mechan-
ism was determined to be immediate pre-programmed
cell death, an apoptotic mechanism that does not
require protein synthesis post-insult, by quantifying
the apoptotic cells over time in the absence or presence
of a translation inhibitor. To explore how UVA1 radi-
ation induces immediate pre-programmed cell death
apoptosis, reactive oxygen species and mitochondrial
activity were altered during exposure using a variety
of agents, while a specific fluorescent probe, 5,59,6,69-
tetrachloro-1,19,3,39-tetraethylbenzimidazolcarbo-
cyanine iodide, was used to examine mitochondrial
Ultraviolet radiation (UVR) can be used to treat avariety of skin diseases. Physicians use the longerwavelengths of UVR, sometimes with a photo-sensitizer, because they penetrate more efficientlyto the dermal layer of the skin: UVA1 wavelengths
(340–400 nm) penetrate up to 30% and UVB wavelengths (290–
320 nm) penetrate up to 10%, while UVC wavelengths (200–
290 nm) only penetrate up to 1% (Bruls et al, 1984). UVA1
phototherapy is used to treat atopic dermatitis (Krutmann, 1996,
1997), lupus erythematosus (McGrath, 1994, 1997), urticaria pig-
mentosa (Stege et al, 1996), pansclerotic morphoea (Gruss et al,
1997), and localized scleroderma (Stege et al, 1997). UVA1 radiation
is reported to mediate singlet-oxygen damage that kills cells by
initiating apoptosis (Morita et al, 1997). Apoptosis is a physiologic
mode of cell death where individual cells shrink to less than half
their volume and fragment into membrane-contained bodies, which
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transmembrane depolarization. To show that UVA1
mediates singlet-oxygen damage to the mitochondrial
membranes, X-rays, UVB (290–320 nm), 8-methoxyp-
soralen and UVA, vitamin K3, anti-Fas antibody, and
blocking antibody were the negative controls, while
rose bengal or protoporphyrin IX with visible light
were the positive controls. Cyclosporine A, which
inhibits the mitochondrial megapore from opening,
was used with singlet-oxygen and superoxide-anion
generators to distinguish between the two final apop-
totic pathways. The collective results show that UVA1
radiation primarily mediates singlet-oxygen damage
triggering immediate pre-programmed cell death
apoptosis (T < 20 min) by immediately opening the
cyclosporine A-sensitive (‘‘S’’ site) mitochondrial
megapore, while superoxide anions initiate another
cyclosporine A-insensitive (‘‘P’’ site) final apoptotic
pathway. Key words: apoptosis/cyclosporine A/mitochon-
drial transmembrane potential/reactive oxygen species. J Invest
Dermatol 112:3–12, 1999
are removed by phagocytosis averting inflammation and tissue
damage (Kerr et al, 1972).
Because phototherapies kill diseased cells by initiating apoptosis,
understanding how they work is crucial for controlling the ultimate
outcome. For example, conventional phototherapies, like PUVA
(8-methoxypsoralen and UVA; 320–400 nm), primarily kill cells
by causing DNA damage that initiates delayed apoptosis, or the
programmed cell death (PCD) mechanism (Marks and Fox, 1991;
Vowels et al, 1996; Yoo et al, 1996). UVR-induced PCD is a
delayed (.4 h) apoptotic mechanism that usually depends on
accumulating p53 (Wang et al, 1998; Godar, unpublished results)
and upregulating certain proteins (Godar, 1996), some of which
are mutated and completely nonfunctional in at least a fraction of
the diseased cell population (e.g., p53–/–). In contrast, UVA1
radiation primarily kills cells by causing oxidative damage that
initiates immediate apoptosis (Godar and Lucas, 1995; Pourzand
et al, 1997), or pre-PCD (Godar, 1996). UVA1-induced pre-PCD
is an apoptotic mechanism that does not depend on accumulating
p53 (Wang et al, 1998; Godar, unpublished results) or upregulating
any proteins, but rather depends on constitutively synthesized
proteins (Godar, 1996), some of which may be mutated but are
still partially functional in every cell. Choosing phototherapies that
initiate the PCD mechanism will eventually select for resistant
mutant populations (e.g., p53–/–) that renders the disease refractory
to treatments that induce these mechanisms, whereas choosing
phototherapies that initiate the pre-PCD mechanism may select for
a different resistant mutant population (e.g., Bcl-2 overexpressors).
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Thus, either altering or combining the different phototherapeutic
approaches, and thus the mechanisms of apoptotic cell death, could
theoretically eliminate all resistant mutant cell populations.
In light of these recent findings, one would think that UVA1
phototherapy might also be a good complimentary phototherapy,
because it kills by an apoptotic mechanism that is different from
conventional phototherapies; however, the apoptotic mechanisms
are not understood well enough yet to optimize the therapeutic
outcome. Thus, this study addresses how UVA1 radiation triggers
apoptotic cell death. In addition to delayed apoptosis, the results
show that UVA1 radiation mediates singlet-oxygen damage that
immediately (T , 20 min) opens the cyclosporine A-sensitive
mitochondrial megachannel, or megapore. This triggers immediate
pre-PCD apoptosis at the ‘‘S’’ site, whereas superoxide anions
trigger another, but not mutually exclusive, final pathway of
apoptosis at the cyclosporine A-insensitive ‘‘P’’ site on the mitochon-
drial membrane.
MATERIALS AND METHODS
Human cells and culture conditions Jurkat (Clone E6–1, acute T cell
leukemia), H9 (T cell lymphoma, derived from the peripheral blood of a
patient with Sezary syndrome), and Daudi (B cell lymphoma, Burkitt),
obtained from the American Type Culture Collection (Rockville, MD),
were cultured and maintained as described previously (Godar and Lucas,
1995; Godar, 1996). Briefly, cell suspensions were grown (1–6 3 105 cells
per ml) in the absence or presence of antibiotics at 37°C in CO2-
independent medium (GIBCO, Grand Island, NY) containing 4 mM
glutamine and 10% heat-inactivated fetal bovine serum (Sigma, St. Louis,
MO), referred to as complete medium.
Radiation sources and dosimetry
UVA1 source The UVASUN sunlamp (Mutzhas, Munich, Germany) emits
wavelengths .340 nm and has an emission peak around 365 nm. The
UVA1 irradiance at the sample level (31 cm) was about 200 W per m2.
The emission spectrum of this UVA1 source (Godar et al, 1994), the
instrument used for routine dosimetric measurements, and the calibration
of the detector were previously described (Godar et al, 1993).
Visible light source The UVASUN sunlamp was equipped with a UF3 cut-
off filter (Read Plastics, Rockville, MD) to yield wavelengths ù400 nm
and was used at a distance of 23 cm for 22.5 min to yield 100 kJ per m2.
UVAR source The UVAR Photoactivation Chamber (Therakos, West
Chester, PA) has an irradiance of about 50 W per m2 through the plastic
top of a T-25 flask at the sample level (16 cm) and 10 min of exposure
gave about 30 kJ per m2.
UVB source The FS20 sunlamp (Westinghouse), which was equipped with
a U340 filter (Hoya Optics, Fremont, CA) to eliminate UVC and reduce
visible and UVA wavelengths, emits mostly UVB wavelengths and has an
emission peak near 313 nm. The UVB irradiance at the sample level
(29 cm) was µ0.48 W per m2 (the UVA irradiance was µ0.32 W per m2).
X-ray source A 120 kV, constant potential, 3 mm Aluminum half-value-
thickness X-ray source was used at a target-to-source distance of 70 cm.
The dose rate was 0.81 Gy per min and 12.35 min of exposure generated
10 Gy of ionizing radiation. A 20 cm thick lucite sheet was used to
backscatter the beam in air for even dosimetry.
Irradiation procedures Unless otherwise specified, all chemicals were
of the highest available purity and were obtained from Sigma. The different
cell culture aliquots were processed for irradiation as described previously
(Godar and Lucas, 1995; Godar, 1996). Briefly, cells were centrifuged,
aspirated, vortexed, and resuspended in phosphate-buffered saline (PBS) to
a final density of 0.4–0.9 3 106 cells per ml. Aliquots of 5 ml were
exposed at room temperature in uncovered 60 mm culture dishes (UV or
visible light), in T-25 flasks (PUVA) where the transmission of UVAR
through the plastic top was adjusted, or in 15 ml polypropylene centrifuge
tubes lying horizontally (X-ray). Following exposure, the samples were
diluted 1:1 with complete medium, placed in T-25 flasks, and incubated
at 37°C.
For experiments inhibiting translation, cells were treated with increasing
concentrations of cycloheximide (CHX; 0.1–10 µg per ml). The CHX
stock solution was 10 mg per ml in ethanol. The role of translation in the
UVA1-triggered immediate apoptotic mechanism was investigated by
pretreating and/or post-treating the cells for 18–24 h with 0.08–10 µg
CHX per ml.
The role of singlet-oxygen damage was investigated by exposing cells
to UVA1 radiation in PBS prepared in either deuterium oxide (100%
D2O and 99.9 atom percentage D) or water (high performance liquid
chromatography grade): sodium azide and sodium cyanide were prepared
in PBS water. Immediately following exposure, these reagents were
removed, after the addition of an equal volume of medium, by centrifuging
and aspirating. The cells were then resuspended in 5–10 ml of fresh
complete medium and incubated at 37°C.
Mitochondrial activity was altered using pyruvate, L-lactate, or somewhat
by D-glucose, whereas sucrose, succinate, fumarate, and citrate in PBS
were the negative controls.
Reduced glutathione (GSH) was used at a final concentration of 10 mM
in PBS during irradiation to quench reactive oxygen species (ROS).
For PUVA experiments, the cells were preincubated in complete medium
with 200 ng 8-methoxypsoralen per ml for 15 min at 37°C before
processing for irradiation as described. The cells were irradiated with about
30 kJ per m2 of UVAR from the Photoactivation Chamber.
Rose bengal (95% dye content) was incubated with the cells for either
1 h or overnight in complete medium using various concentrations. To
generate singlet oxygen, the cells were processed as described and irradiated
with 100 kJ per m2 visible light. The stock solution of Rose bengal was
5 mM in PBS. For experiments involving CsA, cells were centrifuged and
resuspended in fresh medium with 100 µg CsA per ml and incubated at
37°C for 1/2 h before processing for irradiation. CsA was also present at
100 µg per ml during exposure, and at 50 µg per ml after exposure.
The concentration of intracellular protoporphyrin IX was increased
using δ-aminolevulinic acid (ALA; .99% pure as judged by thin layer
chromatography), which is a biochemical precusor of protoporphyrin IX
and is not a photosensitizer. Cells were incubated with either 0.5 or 1 mM
ALA for 2 h at 37°C in complete medium and the increase in protoporphyrin
IX was monitored by fluorescence emission .650 nm (Hryhorenko et al,
1998). The stock solution of ALA was 1 M in dimethlysulfoxide. To
generate singlet oxygen, the cells were processed as described and irradiated
in PBS at room temperature with 100 kJ per m2 visible light. For
experiments involving CsA, a final concentration of 100 µg per ml was
added to the cells during the last 1/2 h of incubation and 100 µg per ml
was present during exposure, and 50 µg per ml after exposure.
Vitamin K3, menadione (.99% pure as judged by thin layer chromato-
graphy), was incubated with the cells in complete medium for up to 24 h
in the dark to generate superoxide anions. The stock solution was 100 mM
in dimethylsulfoxide. For experiments involving CsA, cells were pretreated
with 100 µg CsA per ml for 1/2 h at 37°C, and 100 µg per ml was present
during treatment.
Anti-Fas monoclonal IgM antibody, CH11 (Medical & Biological
Laboratories, Nagoya, Japan), was used to induce apoptosis by incubating
the cells with the recommended concentration (100 ng per ml) in fresh
complete medium for up to 24 h. For experiments involving CsA, cells
were pretreated for 1/2 h at 37°C in fresh complete medium with 100 µg
CsA per ml, which was also present during exposure to anti-Fas antibody.
To block either anti-Fas (positive control) or Fas/FasL-induced apoptotic
pathways, ZB4 (Medical & Biological Laboratories), an anti-Fas monoclonal
IgG blocking antibody, which does not initiate apoptosis, was preincubated
with the cells in fresh complete medium for 1 h at 37°C using twice the
recommended concentration (1 µg per ml). In addition, 1 µg per ml of
ZB4 antibody was present during and after irradiation. An IgG isotype
control (MOPC) was included in parallel samples, which gave the same
values as the PBS controls.
Cyclosporine A (CsA; .96% pure as judged by high performance liquid
chromotography) was preincubated with the cells in complete medium for
1/2 h at 37°C at a final concentration of 100 µg per ml. In addition,
100 µg CsA per ml was present during treatment, and at 50 µg per ml
after irradiation (see individual regimes). The stock solution was 10 mg
per ml in ethanol. The sham-exposed cells included 1% ethanol before
and during irradiation, but only 0.5% afterwards.
Survival: soft agar and liquid chamber plating methods The
reproductive survival values of Jurkat T cells and Daudi B cells were
determined by clonogenicity using the standard soft agar (0.2%) assay
with CO2-independent complete medium and incubating at 37°C (98%
humidity) for 2–3 wk. Macroscopic colonies were counted by eye and
normalized by the sham values. Using these conditions, the plating
efficiencies of the sham-exposed cells were 14 6 4% (range) for Jurkat,
but only 1 6 0.25% for Daudi.
Because Daudi cells do not efficiently form colonies in soft agar, an
alternate ‘‘liquid monolayer chamber plating’’ method had to be developed
to reliably determine these survival values. Slide chambers (1.5 3 30
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ethanol-polished microscope slides with 140 double stick tape near the ends
and in the middle, and a 24 3 60 mm cover glass secured tightly on top)
that are usually used for the hemolytic plaque assay (Cunningham and
Szenberg, 1968), were sterilized, filled with diluted cells (1 3 105 cells per
ml in CO2-independent complete medium), sealed by painting (#4 brush)
with molten Vaseline (50–60°C), and incubated at 37°C without disturbance
for 3–4 d. Near the center of each chamber, a total of two hundred ‘‘units’’
were microscopically (203 magnification) counted as two separate groups:
(i) single cells (nondividing, each cell is one unit) and (ii) clusters of cells
(dividing, each cluster counts as one unit). The survival is calculated by
dividing the number of units that formed clusters of two or more cells by
the total number of units (200). The surviving fraction is the exposed-
survival value divided by the sham-survival value. The liquid chamber
plating method significantly increased the plating efficiency of both cell
lines. The plating efficiency of the Jurkat T cells increased from 14% to
54%, whereas the plating efficiency of the Daudi B cells increased from
1% to 43%.
Transmission electron microscopy Four hours following exposure to
different doses of UVA1 radiation, the transformed T and B cells were
fixed for 1 h at room temperature using 3% glutaraldehyde in PBS and
processed for transmission electron microscopy as described previously
(Godar et al, 1994).
Flow cytometry: percentages of apoptotic cells, Annexin V binding,
and mitochondrial transmembrane potential (DYm) Flow cytome-
try was performed using a single beam 488 nm coherent excitation source
(Becton Dickinson, San Jose, CA). The percentages of apoptotic cells were
determined using a flow cytometric method previously described (Dive
et al, 1992). Briefly, 10,000 cells were analyzed as dot plots using LYSYS
II software (Becton Dickinson) according to the distribution in the side
light-scatter profile (proportional to cellular granularity) versus the forward
light-scatter profile (proportional to cellular cross-sectional area or size).
The apoptotic cells are significantly smaller than the normal cell population.
Annexin V-fluorescein isothiocyanate (FITC; PharMingen, San Diego,
CA) binding to phosphatidyl serine residues on the exterior of the plasma
membrane is one of the earliest markers of apoptosis. The standard operating
procedure recommended by the company was used to analyze the cells.
Mitochondrial transmembrane potential, ∆Ψm, was measured using a
specific fluorescent probe, 5,59,6,69-tetrachloro-1,19,3,39-tetraethylbenzi-
midazol-carbocyanine iodide (JC-1; Molecular Probes, Eugene, OR),
which was incubated at 37°C for 10–20 min with the cells at a final
concentration of 1 µg per ml (Salvioli et al, 1997). The JC-1 stock solution
was 1 mg per ml in dimethylsulfoxide. The FACscan settings vary somewhat
between procedures and cell types. The following settings are recommended
for this procedure and these leukemia and lymphoma cells: FL1
(530 6 15 nm) in log data collection mode with a PMT setting around
425, and FL2 (585 6 20 nm) in log data collection mode with a PMT
setting around 310. Although compensation is not necessary for accurate
quantitation, the different populations may be further separated for better
qualitative presentation: FL1-FL2% is recommended at 1.2–1.4 and FL2-
FL1% is recommended at 22.4–23.2 for Jurkat T cells. The data was
analyzed using two-dimensional dot plots of the yellow (FL2) versus
the green (FL1) fluorescent profiles. The morphologically normal cells
expressing high ∆Ψm are plotted in the figures.
RESULTS
UVA1 radiation reduces the clonogenic survival of trans-
formed lymphocytes in a linear dose-dependent manner
UVA1 radiation reduces the clonogenic survival, which measures
reproductive capacity, of transformed human T (Jurkat) and B
(Daudi) cells in a linear dose-dependent manner (Fig 1).
Figure 1(A) shows the survival curves of the transformed T and
B cells following increasing doses of UVA1 radiation using the
standard clonogenic survival assay in soft agar with CO2-independ-
ent medium. Using the new liquid monolayer chamber plating
technique, survival data were obtained to reliably compare the
sensitivity of the transformed T and B cells to UVA1 radiation
(Fig 1B). The results deceivingly suggest that transformed T cells
are more resistant to UVA1-induced cell killing than transformed
B cells, when actually lymphoma cells (Daudi B cells and H9 T
cells; the later results are not shown) are more sensitive than
leukemia (Jurkat) cells. The linear decline in survival and lack of a
shoulder region indicates lack of DNA repair, which is typical of
lymphocytic cell lines.
Figure 1. UVA1 radiation reduces the reproductive capacity of
transformed human T (Jurkat) and B (Daudi) lymphocytes in a
dose-dependent manner. (A) Clonogenic survival of transformed human
T (j) and B (m) cells using the standard soft agar assay; (B) clonogenic
survival of transformed human T (j) and B (m) cells using the liquid
monolayer chamber plating method. Survival data were obtained in
quadruplicate for four separate experiments (n 5 12–16), where the data
in part (A) was obtained in parallel with the data in (B) using the
same sham- and exposed-cell populations. The error bars represent the
mean 6 SEM.
UVA1 radiation kills transformed lymphocytes by apoptosis
UVA1 radiation kills transformed lymphocytes by initiating
apoptosis rather than necrosis, as shown in Fig 2. Parts (A) and
(B) represent the sham- and UVA1-irradiated (600 kJ per m2)
transformed human T lymphocytes, respectively. Parts (C) and
(D) represent the sham- and UVA1-irradiated (200 kJ per m2)
transformed human B lymphocytes, respectively. Parts (B) and (D)
show transformed apoptotic T and B lymphocytes, respectively,
4 h after UVA1 exposure. Apoptosis is the mode of cell death as
shown by the characteristic morphologic and ultrastructural changes:
cell shrinkage, membrane blebbing, formation of apoptotic bodies,
dilation of rough endoplasmic reticulum (vacuoles), chromatin
digestion and condensation along the nuclear membrane, and
nuclear fragmentation.
UVA1 radiation induces dose- and time-dependent apoptosis
of transformed human lymphocytes The percentages of apop-
totic transformed T and B lymphocytes were quantitated using
flow cytometry at 4 and 24 h after UVA1 exposure (Fig 3).
Although significant percentages of apoptotic cells were observed
immediately following irradiation, a phenomenon referred to as
immediate apoptosis (Godar et al, 1994; Godar and Lucas, 1995),
the results are shown at 4 h to give ample time for all cell types to
undergo this apoptotic process (Fig 3A). UVA1 radiation induces
6 GODAR THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Figure 2. Transmission electron
microscopy reveals apoptotic trans-
formed human T and B cells 4 h
after UVA1 exposure. (A) Sham-exposed
Jurkat T cells; (B) UVA1-exposed (600 kJ
per m2) Jurkat T cells; (C) sham-exposed
Daudi B cells; (D) UVA1-exposed (200 kJ
per m2) Daudi B cells. Similar results were
obtained in three separate experiments.
Scale bar: 2 µm.
dose- and time-dependent apoptosis. The leukemia cells are more
resistant than the lymphoma cells (H9 results not shown) to UVA1-
induced immediate apoptosis, which is in agreement with the
survival data obtained using the liquid monolayer chamber plating
method. Figure 3(B) shows that the percentage of apoptotic
transformed leukemia T cells continues to significantly increase
with increasing dose of UVA1 radiation between 4 and 24 h
following exposure. Thus, in addition to immediate apoptosis,
UVA1 radiation also induces at least delayed apoptosis.
Annexin V-FITC binding confirms the presence of apoptotic
cells To confirm that apoptosis is indeed occurring after UVA1
irradiation, Annexin V-FITC labeling was used (Fig 4). Histogram
profiles of sham-exposed cells (filled) and UVA1-exposed (800 kJ
per m2) cells (empty) are shown immediately after exposure
(Fig 4A), 4 h after exposure (Fig 4B), and 24 h after exposure
(Fig 4C). Annexin V-FITC binding increases in a dose- and time-
dependent manner for doses above 200 kJ per m2 (Fig 4D). This
technique underestimates the percentage of apoptotic cells due to
loss of cells during processing, whereas forward- versus side-scatter
profiles overestimate the percentage due to the presence of apoptotic
bodies. Nevertheless, both techniques show a dose- and time-
dependent increase in the percentage of apoptotic cells. Thus,
UVA1 irradiation of transformed lymphocytes triggers apoptotic
cell death.
Inhibiting translation can induce apoptosis, but it cannot
reduce UVA1-mediated apoptosis Inducing or reducing
apoptosis by inhibiting translation was investigated (Fig 5). Similar
to previous results obtained with transformed mouse T cells (Godar,
1996), increasing concentrations of CHX alone induces apoptosis
of transformed human T cells (Fig 5A) and B cells (results not
shown). Pre-treating and post-treating Jurkat T lymphocytes for
18–24 h with CHX at 0.08 µg per ml did not inhibit UVA1-
triggered immediate apoptosis (Fig 5B). This concentration of
CHX induces very little apoptosis (ø10%) over a 48 h period,
whereas it inhibits both protein synthesis and UVB/C-induced
delayed PCD apoptosis by about 50% (Godar, 1996). Moreover,
the addition of various concentrations of CHX (0.08–10 µg per
ml) either before and/or after UVA1 irradiation had no inhibitory
effect, but rather could enhance UVA1-triggered immediate
apoptosis (results not shown). Thus, UVA1-triggered immediate
apoptosis of transformed human T and B lymphocytes does not
require the synthesis of new proteins, a mechanism termed pre-
PCD (Godar, 1996).
UVA1 radiation reduces the DYm in a dose- and time-
dependent manner Because at least one primary initiation site
of a final pathway of apoptosis is located on the mitochondrial
membrane (Kroemer et al, 1997), and overexpression of a mitochon-
drial antioxidant protein, Bcl-2, prevents immediate apoptosis
(Pourzand et al, 1997), ∆Ψm was monitored with a specific
fluorescent probe, JC-1, using flow cytometry (Salvioli et al, 1997).
UVA1 radiation causes immediate (T , 20 min) dose-dependent
depolarization of the mitochondrial membranes of morphologically
normal transformed T cells (Fig 6). The ∆Ψm of the individual
populations, i.e., either the apoptotic or the morphologically normal
cells, is determined by gating on that population in the side
(granularity) versus the forward (size) light-scatter profiles as shown
in Fig 6(A). Each population is then individually analyzed in dot
plots of the yellow (FL2) versus green (FL1) fluorescent profiles.
Examples are shown for a 600 kJ per m2 UVA1-exposed sample.
Figure 6(B) shows the ∆Ψm of the apoptotic cell population,
whereas Fig 6(C) shows the ∆Ψm of the morphologically normal
cell population. The apoptotic cell population has depolarized
mitochondrial membranes as shown by the region labeled ‘‘low’’
(Fig 6B), whereas most of the morphologically normal population
had a ‘‘high’’ ∆Ψm (Fig 6C). Increasing doses of UVA1 radiation
causes H9, Daudi (results not shown), and Jurkat (Fig 6D) cells to
display a dose- and time-dependent decrease in the ∆Ψm. Thus,
the mitochondrial membranes are immediately (T , 20 min)
depolarized by UVA1 radiation in a dose- and time-dependent
manner, before any morphologic changes occur.
UVA1 mediates primarily singlet-oxygen damage The find-
ing that UVA1 reduces the ∆Ψm in a dose-dependent manner
raised a question about the role of singlet oxygen in UVA1-
triggered immediate apoptosis, because the reagents used also
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Figure 3. UVA1 radiation causes dose- and time-dependent
apoptosis of transformed T and B human lymphocytes. (A) Four
hours after exposure; (B) 24 h after exposure: j, Jurkat; m, Daudi. The
data represent three separate experiments (n 5 3–5) and the error bars
represent the mean 6 SEM.
disrupt ∆Ψm. To re-investigate the role of singlet oxygen in UVA1-
triggered apoptosis, sodium cyanide (1 mM) was used along with
the standard reagents to uncouple oxidation from phosphorylation
and decrease ∆Ψm, while not prolonging the lifetime of or
quenching the production of singlet oxygen. The standard reagents
used are a half-life extender (10–15 times longer), deuterium oxide
(100%), and a singlet-oxygen quencher, sodium azide (50 mM).
The results in Fig 7(A) suggest that UVA1 mediates singlet-oxygen
damage because deuterium oxide significantly increases and azide
significantly decreases immediate apoptosis, while cyanide has little
effect. Figure 7(B) shows the ∆Ψm at 0, 4, and 24 h of the sham-
or UVA1-exposed cells. Although these reagents almost completely
depolarized the mitochondrial membranes of the sham-treated cells
(results not shown), they all returned to normal immediately after
their removal, if within 2 h, and the mitochondrial activity of these
cells remained fairly high for 24 h. This shows that mitochondrial
membrane depolarization can be a reversible event in certain
situations, in agreement with a previous report (Crompton et al,
1987). Collectively, the results suggest that singlet-oxygen damage
caused depolarization of the mitochondrial membranes.
Various inducers of apoptosis Enhancing the life time and
quenching the production of singlet oxygen is only superficial
evidence that suggests UVA1 mediates singlet-oxygen damage,
which is responsible for immediate pre-PCD apoptosis. To help
reveal the actual mechanism(s) various inducers of apoptosis were
used to produce different ROS, including singlet-oxygen and
Figure 4. Annexin V binding to exterior phosphatidylserine residues
on apoptotic cells detected by flow cytometry. Jurkat T cells were
exposed to 800 kJ UVA1 radiation per m2 and labeled with Annexin V-
FITC after exposure. (A) T 5 0, (B) T 5 4 h, (C) T 5 24 h, and (D)
plot of UVA1-dose response of Annexin V binding over time. The sham-
exposed cells are represented by the filled-in histograms, whereas the
UVA1-exposed cells are superimposed as empty histograms. The data
represent three separate experiments (n 5 3), and the error bars represent
the mean 6 SEM.
superoxide-anion generators (Fig 8A). X-rays are known to cause
DNA damage and radiolysis of water yielding primarily hydroxyl
radicals, with some hydrogen peroxide and superoxide anions
produced through side reactions. When 10 Gy of X-rays (.99.999%
clonogenic death) were used on Jurkat T cells (or H9; results not
shown), however, only the delayed PCD apoptotic mechanism was
observed to occur, which peaked near 72 h (results not shown).
In addition, PUVA and moderate doses of UVB (100 J per m2;
95% clonogenic death) also primarily cause DNA damage via
mechanisms that do not involve ROS, but rather direct absorption
by the photosensitizer and/or the DNA. Neither PUVA nor UVB
caused immediate pre-PCD apoptosis, but rather delayed PCD
apoptosis. The small percentage of cells that underwent immediate
apoptosis after PUVA treatment was from the UVA irradiance
alone, as observed by the UVA control that had the same T 5 0
value as PUVA (results not shown). Besides DNA damage, high
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Figure 5. CHX alone induces apoptosis of transformed Jurkat T
helper cells, but fails to inhibit UVA1-induced immediate apoptosis.
(A) Increasing concentrations of CHX on transformed human T cells over
time; (B) 4 h after increasing doses of UVA1 radiation on transformed T
cells that were either untreated or pretreated and post-treated for 18–24 h
with 0.08 µg CHX per ml. The data represent three separate experiments
(n 5 3), and the error bars represent the mean 6 SEM.
doses of UVB (500 J per m2 with .99.999% clonogenic death)
also generate hydroxyl radicals (Gorman et al, 1997); however,
immediate apoptosis did not occur, but rather an ‘‘intermediate’’
(T . 0.5 h , 4 h) mechanism (Wang et al, 1997). On the other
hand, Fas ligation is not induced by DNA damage and is not
initiated by ROS (Marchetti et al, 1997). Cross-linking Fas with
antibodies does not trigger immediate apoptosis, but rather an
intermediate mechanism with kinetics almost identical to high
doses of UVB. With the exception of high-dose UVB radiation
(Aragane et al, 1998), the Fas pathway can be inhibited by a
blocking antibody, like ZB4 (compare in Fig 8A). In contrast,
UVA1-triggered apoptosis was not inhibited by the Fas blocking
antibody, ZB4, again confirming that immediate apoptosis is
triggered by ROS. To investigate the possible role of superoxide
anions in immediate apoptosis, pyruvate was used (Halliwell and
Gutteridge, 1991), but it alone had no effect (results not shown)
unless the cells were irradiated with UVA1. Remarkably, all the
pyruvate, UVA1-treated cells were killed within 5 min after a
moderate dose (400 kJ per m2) of UVA1 radiation. The superoxide
anions produced by pyruvate may have depleted the GSH supply.
This depletion may have increased the cells sensitivity to UVA1-
mediated singlet-oxygen production, because simultaneous addition
of GSH with pyruvate inhibited immediate apoptosis on a mole
to mole basis. Alternatively, and possibly simultaneously, sufficient
pyruvate may have been converted to lactate, which indirectly
depletes the glutathione supply through the enzymatic action of
lactate dehydrogenase. This enzymatic action depletes the reduced
nucleotide pool by producing NAD1, which in turn decreases the
reduced glutathione pool. Thus, another superoxide generator,
vitamin K3, was used to eliminate this possibility in order to
establish if superoxide anions alone could trigger the immediate
apoptotic mechanism. Low to moderate concentrations of vitamin
K3 (,100 µM) did not trigger immediate apoptosis, but rather
intermediate and delayed apoptosis; however, very high concentra-
tions (1 mM) of vitamin K3 killed all the cells within 15 min
(results not shown). This result shows that high amounts of
superoxide anions can also trigger immediate apoptosis. To investi-
gate the possible role of singlet oxygen, rose bengal with visible
light was used (Lambert and Kochevar, 1996) and it triggered
immediate apoptosis. Another approach was used to generate singlet
oxygen, visible light, and protoporphyrin IX, an endogenous ligand
of the benzodiazepine receptor that is an outer mitochondrial
membrane component of the megapore (Pastorino et al, 1994).
ALA, which is a metabolic precusor of protoporphyrin IX and is not
a photosensitizer, was used to increase intercellular concentrations of
protoporphyrin IX, whereby exposure to visible light generates
singlet oxygen (Fernandez et al, 1997). Again, immediate apoptosis
was observed to occur. Collectively, the results show that both
singlet oxygen and superoxide anions can trigger immediate
apoptosis if produced in adequate amounts; however, singlet oxygen
readily triggered immediate apoptosis, whereas only very high
levels of superoxide anions could trigger immediate apoptosis. In all
cases, when apoptosis was triggered the mitochondrial membranes
depolarized before any morphologic changes were observed
(Fig 8B).
CsA inhibits the release of apoptosis initiating factor from
the megapore and the singlet oxygen-triggered immediate
final apoptotic pathway, but CsA does not inhibit the
superoxide anion-initiated final apoptotic pathway CsA was
used to inhibit the release of apoptosis initiating factor from the
megapore (Fig 9). The control CsA culture showed very little
immediate or intermediate apoptosis, but had a significant increase
in the number of apoptotic cells after 24 h, which may be
from inhibition of protein phosphatase 2B, calcium efflux, or
mitochondrial dysfunction (Fig 9A). Short-term use of CsA,
however, can distinguish between apoptotic mechanisms that do
involve the opening of the megapore and those that do not.
Apoptosis initiated by anti-Fas IgM antibody was not inhibited by
CsA, and in fact was increased at 4 and 24 h. The superoxide
generator, vitamin K3, was also unaffected by CsA, and apoptosis
was also increased at later time points. Immediate apoptosis triggered
by very high concentrations of vitamin K3 (1 mM) could not be
inhibited by CsA (data not shown), demonstrating that even when
superoxide anions trigger immediate apoptosis it occurs through
another final apoptotic pathway. CsA also did not inhibit the
pyruvate/UVA1 superoxide anion generating system. Note that
apoptosis triggered by pyruvate and UVA1 radiation was inhibited
by the presence of 1% ethanol, as seen in this figure compared
with the pyruvate result in Fig 8(A) that did not have ethanol
present. Although ethanol also scavenges hydroxyl radicals, another
hydroxyl radical scavenger, dimethylsulfoxide, had no effect even
at twice the concentration (2%; results not shown). In contrast to the
superoxide-anion generating systems, UVA1-triggered immediate
apoptosis was significantly, though not completely, inhibited by
CsA, and so were the other singlet oxygen systems, i.e., rose bengal
or protoporphyrin IX with visible light. Although CsA inhibited
immediate apoptosis, it did not prevent the immediate depolariza-
tion of the mitochondrial membranes (Fig 9B). Together the results
show that UVA1 radiation triggers immediate apoptosis through
two different final apoptotic pathways, one is CsA sensitive and
the other is not.
DISCUSSION
The results presented in this paper reveal the existence of two
‘‘points-of-no-return’’ on the mitochondrial membrane that can
trigger immediate apoptosis through two different final apoptotic
pathways. One pathway is triggered by singlet oxygen and is
inhibited by CsA (the megapore ‘‘S’’ site), whereas the other
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Figure 6. UVA1 irradiation of transformed Jurkat T cells immediately (T < 10 min post-exposure) reduces the DYm in a dose- and time-
dependent manner. Monitoring of ∆Ψm occurred with a specific probe, JC-1 (see Materials and Methods for details). Part (A) shows the side (granularity)
versus the forward (side) light-scatter profile of a 600 kJ UVA1 per m2 exposed sample immediately after exposure. The apoptotic cells are smaller than
the normal population as displayed by the region markers in the dot plot. Part (B) shows the ∆Ψm of only the apoptotic cells in a yellow (FL1) versus
green (FL2) fluorescent dot plot profile after gating on this population in the side versus the forward light-scatter profile as shown in (A). Apoptotic cells
display ‘‘low’’ ∆Ψm as indicated in the region marker. Part (C) shows only the morphologically normal cells, after gating from (A), immediately following
600 kJ UVA1 radiation per m2: these cells show both ‘‘low’’ and ‘‘high’’ ∆Ψm. Dose- and time-dependent depolarization of the mitochondrial membranes
of the morphologically normal leukemia T cells (Jurkat) is shown in (D). The error is not plotted in the graph because it was less than 3% (SEM) for all
data points.
pathway is triggered by superoxide anions and is not inhibited
by CsA (the ‘‘P’’ site). Evidently, UVA1 radiation mediates the
production of both singlet oxygen and superoxide anions to
different degrees, which causes both immediate (T , 20 min) and
delayed (T . 4 h) apoptosis. UVA1-triggered immediate pre-PCD
apoptosis can be inhibited with CsA, though not completely, but
pyruvate UVA1-triggered immediate apoptosis cannot be inhibited
with CsA. CsA keeps the megapore from opening and releasing
apoptosis initiating factor (Kroemer et al, 1997), but it cannot keep
the mitochondrial transmembrane from depolarizing, suggesting
that calcium can efflux in its presence. The singlet oxygen gener-
ators, rose bengal or protoporphyrin IX with visible light, trigger
immediate apoptosis in a moderate dose range; whereas the super-
oxide anion generator vitamin K3 only triggers immediate apoptosis
at very high concentrations. Reasonable levels of superoxide anions
initiate intermediate and delayed apoptosis, neither of which can
be inhibited with CsA. Furthermore, any agent that initiates
intermediate or delayed apoptosis cannot be inhibited with CsA.
Only singlet oxygen generating systems, such as UVA1 radiation,
rose bengal, or protoporphyrin IX with visible light, can trigger
immediate apoptosis, which can be inhibited, though not com-
pletely, with CsA. The results show that UVA1 radiation triggers
immediate apoptosis through a megapore opening at the ‘‘S’’ site,
and because CsA does not completely inhibit immediate apoptosis,
suggests that superoxide anion formation and channel formation at
the ‘‘P’’ site may occur to some extent. Thus, UVA1 radiation
triggers apoptosis at two different points-of-no-return, which have
different corresponding final pathways of apoptosis (for a recent
review see Godar, 1999).
A model for immediate, intermediate, and delayed apoptosis,
including the ‘‘S’’ and ‘‘P’’ sites of the megapore (Costantini et al,
1996) and how the two final apoptotic pathways may work, is
shown in Fig 10. Immediate apoptosis is triggered by singlet
oxygen (this paper) that causes damage to the megapore (see Fig 10,
bottom left). The megapore opens and releases apoptosis initiating
factor unless CsA or Bcl-2 is present (Susin et al, 1996); whereas
superoxide-anion generating systems and all signal transduction
pathways initiate intermediate or induce delayed apoptosis evidently
through Bax channel formation at the ‘‘P’’ site (Jurgensmeier et al,
1998), which cannot be inhibited by CsA. The CsA-insensitive
‘‘P’’ site initiates the morphologic changes associated with apoptosis
by releasing cytochrome c (cyto c in Fig 10; Bossy-Wetzel et al,
1998), which is also blocked by Bcl-2 (Kluck et al, 1997). Bcl-2,
an antioxidant protein (Hockenbery et al, 1993; Pourzand et al,
1997), is associated with the outer mitochondrial membrane and
inhibits both sites by playing a dual role. One role of Bcl-2 controls
megapore opening and the thiol status (Marchetti et al, 1997),
whereas the other regulates Bax channel formation (Jurgensmeier
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Figure 7. UVA1 mediates singlet-oxygen damage that results in
immediate (T J 0) apoptosis and immediate (T J 0) depolarization
of the DYm before any apoptotic morphologic changes. Part (A)
shows the percentages of apoptotic cells in the sham- (left side) and UVA1-
exposed (800 kJ per m2; right side) samples at 0, 4, and 24 h after exposure.
Part (B) shows the percentage of morphologically normal cells in the sham-
(left side) and the UVA1-exposed (800 kJ per m2; right side) samples that
have a high ∆Ψm, as demonstrated in Fig 6, at 0, 4, and 24 h after
exposure. 0, PBS; D2O, deuterium oxide (100%); N3, sodium azide
(50 mM); CN, sodium cyanide (1 mM). The results represent three separate
experiments, and the error was , 3% unless represented by error bars (SEM).
et al, 1998) and the transmembrane potential (Marchetti et al, 1996).
The ‘‘P’’ site can be opened by superoxide anion generating systems,
though hydroxyl radicals that are created through the Fenton and/
or Haber-Weiss reactions after superoxide dismutase forms hydrogen
peroxide may cause the actual damage.
Intermediate apoptosis is initiated by receptors on the plasma
membrane (see Fig 10, top middle to bottom left). Unlike X-rays
or PUVA, using very high doses of UVB initiates a rapid, but not
immediate apoptotic mechanism. This finding is in agreement with
the observations of others who used high doses of UVB (Martin
et al, 1995; Aragane et al, 1998; Bossy-Wetzel et al, 1998). The
kinetics of the high-dose UVB mechanism matches that of the
anti-Fas-induced apoptotic mechanism because it causes cross-
linking of the Fas receptor independent of engagement with its
ligand (Aragane et al, 1998), which may occur through the formation
of hydroxyl radicals (Gorman et al, 1997). Engaging the Fas receptor
with either its ligand or anti-Fas antibody initiates an apoptotic
mechanism that is also rapid (2–4 h), though not the same as
immediate (T 5 0) apoptosis, but rather kinetically ‘‘intermediate’’
(Wang et al, 1997). The anti-Fas-initiated apoptotic mechanism
can be inhibited with a blocking antibody, which also restores ∆Ψm,
unlike UVA1-triggered immediate apoptosis where no significant
inhibition was observed at 800 kJ per m2 or lower doses (400 kJ
per m2; results not shown). Although it is possible that UVA1
radiation may also cross-link the Fas receptor, the kinetics do not
match immediate apoptosis. Thus, UVA1-triggered immediate
apoptosis does not involve the Fas pathway, a mechanism that does
not require DNA damage or ROS for initiation. After UVB causes
Fas to be cross-linked on the plasma membrane, a premitochondrial
caspase cascade is activated (Aragane et al, 1998). Evidently this
causes Bax to form channels at the ‘‘P’’ site releasing cytochrome
Figure 8. Various inducers of apoptosis. All sham-exposed populations
were within 5% of that shown as 0 in the figure, except the UVA control
for PUVA, which had the same value at T 5 0 as PUVA. (A) Percentage
of apoptotic cells; (B) percentage of morphologically normal cells having
a high mitochondrial transmembrane potential. 0, PBS; Xray, 10 Gy
(.99.999% clonogenic killing); PUVA, 200 ng 8-methoxypsoralen per ml
and 30 kJ UVAR have a high ∆Ψm, as demonstrated in Fig 6, at 0, 4,
and 24 h after exposure. UVB/Hi, UVB high dose (500 J per m2;
.99.999% clonogenic killing); Fas 1 0, anti-Fas antibody CH11 without
ZB4 pretreatment; Fas 1 ZB4, anti-Fas antibody CH11 first pretreated
with ZB4 inhibiting antibody; UVA1 1 0, 800 kJ per m2 without ZB4
pretreatment; UVA1 1 ZB4, 800 kJ per m2 first pretreated with ZB4
inhibiting antibody; UVA1 1 P 1 0, 400 kJ per m2 1 pyruvate
(10 mM) 1 0 GSH; UVA1 1 P 1 G, 400 kJ per m2 1 pyruvate
(10 mM) 1 GSH (10 mM); Vit K3, vitamin K3 (25 µM); Rose, rose
bengal (25 µM overnight incubation) and 100 kJ per m2 visible light;
ALA, delta-aminolevulinic acid (0.5 mM) and 100 kJ per m2 visible light.
The results represent three separate experiments, and the error was ,3%
unless represented by error bars (SEM).
c, which activates a post-mitochondrial caspase cascade that leads
to apoptotic morphology.
Delayed apoptosis is induced by DNA damage (see Fig 10,
bottom right to left). DNA damage is caused by X-rays, UVC,
UVB, UVA, and visible light (Ley and Applegate, 1985; Jones et al,
1987; Peak and Peak, 1991). The UVA1-induced delayed apoptotic
mechanism results in increased expression of the Fas ligand on the
membrane, which initiates apoptosis by cross-linking the already
expressed Fas receptor (Morita et al, 1997). This may occur through
the action of the transcription factor AP-1, because this was
observed to occur in other DNA damage-induced delayed apoptotic
mechanisms, which include UVB (Kasibhatla et al, 1998). Unlike
other DNA damage mechanisms, UVA1-induced delayed apoptosis
is a p53-independent mechanism (Wang et al, 1998; Godar, unpub-
lished results). X-rays also cause increased expression of the Fas
ligand (Belka et al, 1998). In addition, another DNA damage-
induced apoptotic mechanism involving p53 has been reported for
X-rays (Clarke et al, 1993; Lowe et al, 1993), PUVA (Marks and
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Figure 9. CsA distinguishes between the two, not mutually
exclusive, final pathways of apoptosis. Cells were treated as described
in the Materials and Methods. All sham-exposed populations, except CsA,
were within 5% of that shown as 0 in the figure. (A) Percentage of
apoptotic cells; (B) percentage of morphologically normal cells having a
high mitochondrial transmembrane potential. 0, PBS with 1% ethanol;
CsA, cyclosporine A (100 µg per ml and 1% ethanol); Fas, anti-Fas antibody
CH11 with 1% ethanol; Fas 1 CsA, anti-Fas antibody pretreated with
CsA; Vit K3, vitamin K3 (100 µM and 1% ethanol); Vit K3 1 CsA, vitamin
K3 pretreated with cyclosporine A; UVA1 1 P, 400 kJ per m
2 UVA1 1
pyruvate (10 mM with 1% ethanol); UVA1 1 P 1 CsA, 400 kJ per m2
UVA1 1 pyruvate (10 mM with 1% ethanol) 1 pretreatment with CsA;
UVA1, 800 kJ UVA1 per m2 and 1% ethanol; UVA1 1 CsA, 800 kJ UVA1
per m2 and 1% ethanol 1 pretreatment with CsA; Rose, rose bengal
(50 µM for 1 h and 1% ethanol); Rose 1 CsA, Rose bengal (50 µM for
1 h and 1% ethanol) pretreated with CsA; ALA, delta-aminolevulinic acid
(1 mM with 1% ethanol); ALA 1 CsA, delta-aminolevulinic acid (1 mM
with 1% ethanol) pretreated with CsA. The results represent three separate
experiments, and the error was ,3% unless represented by error bars (SEM).
Fox, 1991; Vowels et al, 1996; Yoo et al, 1996), and UVB (Wang
et al, 1998; unpublished results). Accumulation of p53 causes
upregulation of Bax (O’Grady et al, 1998; Reinke et al, 1997),
which can directly form a channel at the ‘‘P’’ site. Multiple,
or ‘‘fail-safe,’’ DNA damage-induced apoptotic mechanisms may
coexist to ensure that the mutated cell does not survive and replicate.
In conclusion, UVA1 radiation triggers two different final apop-
totic pathways at the ‘‘S’’ and ‘‘P’’ sites of the megapore on the
mitochondrial membrane. This knowledge will help clinicians to
modify phototherapeutic approaches in order to optimize a favorable
outcome when treating different patients. For example, transplant
or HIV infected patients receiving CsA therapy may respond to
UVA1 phototherapy better if pyruvate, or another superoxide
generator like vitamin K3, were applied to their skin before
treatment. Patients that drink a lot of alcohol or tea (high in
antioxidants), take antioxidant vitamins, or are receiving some
therapy or drugs that increase the GSH pool, may respond better
Figure 10. Model for immediate, intermediate, and delayed
apoptosis. Immediate apoptosis is triggered at the mitochondria by singlet
oxygen (1O2) that causes damage to the ‘‘S’’ site of the megapore. Unless
CsA is present, the ‘‘S’’ site opens and releases apoptosis initiating factor
(AIF), which is reported to activate a post-mitochondrial caspase cascade
beginning with caspase 3. Immediate apoptosis can also be triggered at the
mitochondria by superoxide anions (O2
–) that cause damage to the ‘‘P’’
site of the megapore, which is not inhibited by CsA. The actual damage
may be from hydroxyl radicals that are produced by the Fenton and/or
Haber-Weiss reactions after superoxide is converted to hydrogen peroxide
through the enzymatic action of superoxide dismutase. The ‘‘P’’ site releases
cytochrome c (Cyto c), which activates another post-mitochondrial caspase
cascade beginning with caspase 9 and ending with caspase 3. Unlike the
release of apoptosis initiating factor, the release of cytochrome c cannot be
inhibited by CsA. The two final apoptotic pathways evidently involve a
different sequence of post-mitochondrial caspase activation, which are not
mutually exclusive. Intermediate apoptosis is initiated on the plasma
membrane by cross-linking of the Fas receptor, which activates a pre-
mitochondrial caspase cascade beginning with caspase 8. This caspase
cascade evidently opens the megapore at the ‘‘P’’ site through Bax channel
formation, because it cannot be inhibited with CsA. Delayed apoptosis is
induced by DNA damage and either AP-1 upregulating FasL, which then
initiates the intermediate mechanism, or p53 upregulating Bax, which
makes channels in the mitochondrial membrane releasing cytochrome c.
if GSH levels are first reduced. Alternatively, they could reduce or
refrain from these practices during therapy or another singlet-
oxygen generator, such as rose bengal or ALA, could be used along
with UVA1 phototherapy. Future clinical research will determine
which approach is most effective for each patient and disease.
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